Blood Cells, Molecules, and Diseases

Print ISSN
1079-9796
Electronic ISSN
1096-0961
Impact factor
2.716
Publisher
Sciencedirect
URL
http://www.sciencedirect.com/science/journal/10799796
Usage rank
2900
Article count
1517
Free count
64
Free percentage
0.0421885
PDFs via platforms
Ingenta, Gale, Sciencedirect from 1995, and Rcgp

  1. Editorial Board
    Author(s) unavailable

    Blood Cells, Molecules, and Diseases 55(4):IFC (2015)

  2. Corrigendum to “ApoptomiRs expression modulated by BCR–ABL is linked to CML progression and imatinib resistance” [Blood Cells Mol. Dis. 53 (1–2) (June–August 2014) 47–55]

    Blood Cells, Molecules, and Diseases 55(4):420 (2015)

  3. Corrigendum to “Hemoglobin level and morbidity in non-transfusion-dependent thalassemia” [Blood Cells Mol. Dis. 55 (2) (August 2015) 108–109]

    Blood Cells, Molecules, and Diseases 55(4):419 (2015)

  4. A multicenter, open-label extension study of velaglucerase Alfa in Japanese patients with gaucher disease: Results after a cumulative treatment period of 24 months

    Blood Cells, Molecules, and Diseases (2015)

    Enzyme replacement therapy (ERT) with exogenous glucocerebrosidase is indicated to treat symptomatic Gaucher disease (GD), a rare, inherited metabolic disorder. ERT with velaglucerase alfa, which is produced in a human cell line using gene activation technology, was studied in a 12-mon...
  5. Editorial Board
    Author(s) unavailable

    Blood Cells, Molecules, and Diseases 55(1):IFC (2015)

  6. Corrigendum to “Interleukin-1β and interleukin-6 gene polymorphisms are associated with manifestations of sickle cell anemia” [Blood Cells Mol. Dis. 54/3(2014), 244–249]

    Blood Cells, Molecules, and Diseases 54(4):328 (2015)

  7. Editorial Board
    Author(s) unavailable

    Blood Cells, Molecules, and Diseases 54(4):IFC (2015)

  8. Editorial Board
    Author(s) unavailable

    Blood Cells, Molecules, and Diseases 54(3):IFC (2015)

  9. Editorial Board
    Author(s) unavailable

    Blood Cells, Molecules, and Diseases 54(2):IFC (2015)

  10. Editorial Board
    Author(s) unavailable

    Blood Cells, Molecules, and Diseases 54(1):IFC (2015)

  11. Editorial Board
    Author(s) unavailable

    Blood Cells, Molecules, and Diseases 53(4):IFC (2014)

  12. A novel mutation in Wiskott–Aldrich syndrome and successfully treated with umbilical cord blood transplantation

    Blood Cells, Molecules, and Diseases 53(4):283 (2014) PMID 24824128

    We report a novel mutation in a boy with Wiskott–Aldrich syndrome (WAS) who was 4years and 10months of age and underwent successful umbilical cord blood transplantation (UCBT). The child presented at 3months of age with symptomatic thrombocytopenia and eczema. Despite a large dose of i...
  13. Editorial Board
    Author(s) unavailable

    Blood Cells, Molecules, and Diseases 53(3):IFC (2014)

  14. High altitude genetic adaptation in Tibetans: No role of increased hemoglobin–oxygen affinity

    Blood Cells, Molecules, and Diseases 53(1-2):27 (2014) PMID 24618341 PMCID PMC4039493

    High altitude exerts selective evolutionary pressure primarily due to its hypoxic environment, resulting in multiple adaptive responses. High hemoglobin–oxygen affinity is postulated to be one such adaptive change, which has been reported in Sherpas of the Himalayas. Tibetans have live...
  15. BRAF — A new player in hematological neoplasms

    Blood Cells, Molecules, and Diseases 53(1-2):77 (2014) PMID 24495477

    BRAF oncogenic kinase has become a target for specific therapy in oncology. Genetic characterization of a predominant V600E mutation in melanoma, thyroid cancer, and other tumors became a focus for developing specific inhibitors, such as vemurafenib or dabrafenib. Our knowledge regardi...
  16. A yet unreported der(11)t(6;11)(p21;q21) included in a complex karyotype of a refractory anemia with ring sideroblasts and poor prognosis

    Blood Cells, Molecules, and Diseases 53(1-2):91 (2014) PMID 24439112

  17. Gaucher disease: Plasmalogen levels in relation to primary lipid abnormalities and oxidative stress

    Blood Cells, Molecules, and Diseases 53(1-2):30 (2014) PMID 24521822

    Plasmalogens represent a unique class of phospholipids. Reduced red blood cell plasmalogen levels in Gaucher disease patients were reported, correlating to total disease burden. The relation between plasmalogen abnormalities in Gaucher disease patients and primary glycosphingolipid abn...
  18. The role of EVI1 in myeloid malignancies

    Blood Cells, Molecules, and Diseases 53(1-2):67 (2014) PMID 24495476

    The EVI1 oncogene at human chr 3q26 is rearranged and/or overexpressed in a subset of acute myeloid leukemias and myelodysplasias. The EVI1 protein is a 135kDa transcriptional regulator with DNA-binding zinc finger domains. Here we provide a critical review of the current state of rese...
  19. Editorial Board
    Author(s) unavailable

    Blood Cells, Molecules, and Diseases 53(1-2):IFC (2014)

  20. Effects of o-vanillin on K+ transport of red blood cells from patients with sickle cell disease

    Blood Cells, Molecules, and Diseases 53(1-2):21 (2014) PMID 24594314 PMCID PMC4039999

    Aromatic aldehydes like o-vanillin were designed to reduce the complications of sickle cell disease (SCD) by interaction with HbS, to reduce polymerisation and RBC sickling. Present results show that o-vanillin also directly affects RBC membrane permeability. Both the K+–Cl− cotranspor...